QuantaMatrix Inc.
QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early dia… Read more
QuantaMatrix Inc. (317690) - Net Assets
Latest net assets as of September 2025: ₩6.96 Billion KRW
Based on the latest financial reports, QuantaMatrix Inc. (317690) has net assets worth ₩6.96 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩21.61 Billion) and total liabilities (₩14.65 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩6.96 Billion |
| % of Total Assets | 32.22% |
| Annual Growth Rate | N/A |
| 5-Year Change | -88.62% |
| 10-Year Change | N/A |
| Growth Volatility | 57.88 |
QuantaMatrix Inc. - Net Assets Trend (2017–2024)
This chart illustrates how QuantaMatrix Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for QuantaMatrix Inc. (2017–2024)
The table below shows the annual net assets of QuantaMatrix Inc. from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩6.53 Billion | -63.96% |
| 2023-12-31 | ₩18.12 Billion | -54.56% |
| 2022-12-31 | ₩39.88 Billion | -31.70% |
| 2021-12-31 | ₩58.39 Billion | +1.73% |
| 2020-12-31 | ₩57.40 Billion | +96.04% |
| 2019-12-31 | ₩29.28 Billion | +172.78% |
| 2018-12-31 | ₩-40.23 Billion | -50.83% |
| 2017-12-31 | ₩-26.67 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to QuantaMatrix Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 16439114525000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩8.27 Billion | 126.65% |
| Other Components | ₩192.58 Billion | 2948.89% |
| Total Equity | ₩6.53 Billion | 100.00% |
QuantaMatrix Inc. Competitors by Market Cap
The table below lists competitors of QuantaMatrix Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SUN KWANG CO.Ltd
KQ:003100
|
$41.90 Million |
|
Atturra Ltd
AU:ATA
|
$41.91 Million |
|
Urja Global Limited
NSE:URJA
|
$41.92 Million |
|
NAU IB Capital
KQ:293580
|
$41.93 Million |
|
I-Tech
ST:ITECH
|
$41.86 Million |
|
Chi Sheng Chemical
TWO:4111
|
$41.85 Million |
|
Qua Granite Hayal Yapi ve Urunleri Sanayi Ticaret AS
IS:QUAGR
|
$41.84 Million |
|
DK-Lok Corporation
KQ:105740
|
$41.81 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in QuantaMatrix Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 18,119,805,850 to 6,530,650,500, a change of -11,589,155,350 (-64.0%).
- Net loss of 20,168,600,440 reduced equity.
- Share repurchases of 6,500,000 reduced equity.
- New share issuances of 6,500,000 increased equity.
- Other factors increased equity by 8,579,445,090.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-20.17 Billion | -308.83% |
| Share Repurchases | ₩6.50 Million | -0.1% |
| Share Issuances | ₩6.50 Million | +0.1% |
| Other Changes | ₩8.58 Billion | +131.37% |
| Total Change | ₩- | -63.96% |
Book Value vs Market Value Analysis
This analysis compares QuantaMatrix Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.36x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩-2594.45 | ₩3695.00 | x |
| 2018-12-31 | ₩-3913.26 | ₩3695.00 | x |
| 2019-12-31 | ₩2371.67 | ₩3695.00 | x |
| 2020-12-31 | ₩3916.69 | ₩3695.00 | x |
| 2021-12-31 | ₩3543.87 | ₩3695.00 | x |
| 2022-12-31 | ₩2419.96 | ₩3695.00 | x |
| 2023-12-31 | ₩1095.69 | ₩3695.00 | x |
| 2024-12-31 | ₩394.78 | ₩3695.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently QuantaMatrix Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -308.83%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -807.67%
- • Asset Turnover: 0.09x
- • Equity Multiplier: 4.11x
- Recent ROE (-308.83%) is below the historical average (-93.82%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | -26699.35% | 0.00x | 0.00x | ₩-9.76 Billion |
| 2018 | 0.00% | -18261.83% | 0.00x | 0.00x | ₩-11.49 Billion |
| 2019 | -217.94% | -7864.48% | 0.02x | 1.13x | ₩-66.74 Billion |
| 2020 | -25.54% | -867.72% | 0.03x | 1.07x | ₩-20.40 Billion |
| 2021 | -31.02% | -3295.13% | 0.01x | 1.09x | ₩-23.95 Billion |
| 2022 | -48.24% | -1495.97% | 0.03x | 1.14x | ₩-23.23 Billion |
| 2023 | -118.96% | -691.35% | 0.14x | 1.25x | ₩-23.37 Billion |
| 2024 | -308.83% | -807.67% | 0.09x | 4.11x | ₩-20.82 Billion |
Industry Comparison
This section compares QuantaMatrix Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $98,321,642,752
- Average return on equity (ROE) among peers: 7.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| QuantaMatrix Inc. (317690) | ₩6.96 Billion | 0.00% | 2.10x | $41.89 Million |
| Shinhung (004080) | $87.31 Billion | 3.50% | 0.52x | $10.80 Million |
| Osang Healthcare Co.,Ltd (036220) | $199.86 Billion | 20.34% | 0.25x | $37.44 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $246.58 Million |
| JVM Co. Ltd (054950) | $98.83 Billion | 10.23% | 0.72x | $117.37 Million |
| Huvitz Co. Ltd (065510) | $51.68 Billion | 16.97% | 0.32x | $43.64 Million |
| Vieworks Co. Ltd (100120) | $188.04 Billion | 17.80% | 0.28x | $101.54 Million |
| Corentec Co Ltd (104540) | $48.30 Billion | -3.04% | 0.46x | $40.80 Million |
| Hironic Co. Ltd (149980) | $40.72 Billion | 7.13% | 0.15x | $23.71 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $21.68 Million |
| Humasis Co. Ltd (205470) | $229.26 Billion | -13.28% | 0.45x | $48.97 Million |